D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Operating cash flow (Indirect Method) | |||
Cash from operating activities | -5.75%889.87M | 548.73%944.21M | -210.42M |
Net profit before non-cash adjustment | 54.90%680.89M | 25.78%439.58M | --349.49M |
Total adjustment of non-cash items | 61.45%204.12M | 131.06%126.43M | ---407.08M |
-Depreciation and amortization | 0.91%181.98M | 5.88%180.35M | --170.33M |
-Reversal of impairment losses recognized in profit and loss | -99.48%1.03M | 51.21%197.39M | --130.54M |
-Disposal profit | -663.44%-21.32M | 1,100.95%3.78M | --315K |
-Other non-cash items | 116.63%42.42M | 63.98%-255.09M | ---708.26M |
Changes in working capital | -98.71%4.87M | 347.46%378.2M | ---152.83M |
-Change in receivables | -433.94%-100.68M | 75.58%-18.86M | ---77.23M |
-Change in inventory | -188.48%-10.34M | -155.71%-3.59M | ---1.4M |
-Change in payables | -58.49%93.1M | 432.14%224.29M | --42.15M |
-Change in accrued expense | -49.89%56.65M | 957.65%113.05M | ---13.18M |
-Changes in other current assets | -601.92%-43.03M | 92.01%-6.13M | ---76.75M |
-Changes in other current liabilities | -86.79%9.17M | 362.83%69.44M | ---26.42M |
Dividends paid (cash flow from operating activities) | |||
Dividends received (cash flow from operating activities) | |||
Interest paid (cash flow from operating activities) | 10.17%-4.69M | 7.31%-5.22M | -5.64M |
Interest received (cash flow from operating activities) | 10.00%11K | 0.00%10K | 10K |
Tax refund paid | -69.66%-263.09M | -736.86%-155.07M | -18.53M |
Other operating cash inflow (outflow) | 0 | -63.11%264.57M | 717.13M |
Operating cash flow | -40.67%622.11M | 117.28%1.05B | --482.55M |
Investing cash flow | |||
Net PPE purchase and sale | -13.58%-342.18M | 39.56%-301.28M | ---498.44M |
Net business purchase and sale | --0 | ---115M | --0 |
Net changes in other investments | 62.81%-17.4M | -5.28%-46.77M | ---44.43M |
Investing cash flow | 22.35%-359.57M | 14.70%-463.05M | ---542.87M |
Financing cash flow | |||
Net issuance payments of debt | -281.30%-296.31M | -220.42%-77.71M | --64.53M |
Net common stock issuance | --1.55B | --0 | ---- |
Issuance fees | ---4.43M | --0 | ---- |
Net other fund-raising expenses | 0.00%-3.03M | -139.97%-3.03M | ---1.26M |
Financing cash flow | 1,638.15%1.24B | -227.61%-80.74M | --63.27M |
Net cash flow | |||
Beginning cash position | 32.02%2.08B | 0.19%1.58B | --1.57B |
Current changes in cash | 198.07%1.5B | 16,991.47%504.71M | --2.95M |
Cash adjustments other than cash changes | ---- | ---- | --1K |
End cash Position | 72.29%3.59B | 32.02%2.08B | --1.58B |
Free cash flow | -67.90%239.31M | 4,406.42%745.57M | ---17.31M |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |